Ensuring the health and safety of your patients, employees and community at large requires a complete and robust solution for fast COVID-19 screening.

 

To aid in the effort to combat the on-going COVID-19 pandemic, National Labs offers a full-service package that includes both front-end specimen collection as well as back-end testing support, all by a state-of-the-art lab using the most current technology and methods.

 

Partnering with counties, public health departments, hospitals, clinics, businesses, schools, and long term care facilities, we use the RT-PCR testing method under EUA (emergency use authorization) based on anterior nares, nasopharyngeal and saliva specimen types. We also look at 3 genetic markers, instead of just 2, which can capture known COVID variants while eliminating concern over false negatives.

 

National Labs COVID-19 testing services feature:

 

• Average TAT of <24 hours post specimen receipt

• Full service, onsite facility testing and specimen collection

• RT-PCR testing methodology

• EUA (emergency use authorization) testing validation

• Anterior nares, nasopharyngeal and saliva specimen types

• Automated specimen processing

• Acceptance of all insurance providers with no cost to patients

• Competitive contract pricing

• Results reporting via electronic web portal with customized results summary and EMR integration available

Test Name: Covid-19

 

Description: Designed to detect the virus that causes Covid-19 in respiratory specimens for nasal or oral swabs.

 

CPT/HCPCS Codes: U0003, U0005 when applicable

​

Price: We bill health plan or government $100 to $200 depending on the plan. Zero out-of-pocket patient responsibility is expected for medically appropriate testing ordered by an authorized provider.